These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel 2-phenoxypyrido[3,2-b]pyrazin-3(4H)-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity. Hao X, Qi G, Ma H, Zhu C, Han Z. J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930 [Abstract] [Full Text] [Related]
3. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity. Chen H, Zhang X, Zhang X, Fan Z, Liu W, Lei Y, Zhu C, Ma B. Bioorg Med Chem; 2020 Oct 15; 28(20):115699. PubMed ID: 33069078 [Abstract] [Full Text] [Related]
5. Identification of quinoxalin-2(1H)-one derivatives as a novel class of multifunctional aldose reductase inhibitors. Hao X, Qin X, Zhang X, Ma B, Qi G, Yu T, Han Z, Zhu C. Future Med Chem; 2019 Dec 15; 11(23):2989-3004. PubMed ID: 31659919 [Abstract] [Full Text] [Related]
7. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity. Zou Y, Qin X, Hao X, Zhang W, Yang S, Yang Y, Han Z, Ma B, Zhu C. Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3924-7. PubMed ID: 26227780 [Abstract] [Full Text] [Related]
8. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity. Han Z, Hao X, Ma B, Zhu C. Eur J Med Chem; 2016 Oct 04; 121():308-317. PubMed ID: 27267001 [Abstract] [Full Text] [Related]
9. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase. Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J. Eur J Med Chem; 2018 May 25; 152():160-174. PubMed ID: 29705708 [Abstract] [Full Text] [Related]
11. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones. Qin X, Hao X, Han H, Zhu S, Yang Y, Wu B, Hussain S, Parveen S, Jing C, Ma B, Zhu C. J Med Chem; 2015 Feb 12; 58(3):1254-67. PubMed ID: 25602762 [Abstract] [Full Text] [Related]
12. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity. Hao X, Han Z, Li Y, Li C, Wang X, Zhang X, Yang Q, Ma B, Zhu C. Bioorg Med Chem Lett; 2017 Feb 15; 27(4):887-892. PubMed ID: 28109789 [Abstract] [Full Text] [Related]
16. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. Kovacikova L, Prnova MS, Majekova M, Bohac A, Karasu C, Stefek M. Molecules; 2021 May 12; 26(10):. PubMed ID: 34066081 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10. Zhang W, Wang L, Zhang L, Chen W, Chen X, Xie M, Yan G, Hu X, Xu J, Zhang J. Steroids; 2014 Aug 12; 86():39-44. PubMed ID: 24793566 [Abstract] [Full Text] [Related]